The Effect of Pessary Post Vaginal Prolapse Repair, for One Month, to Reduce the Recurrence Rate of Prolapse (pfgp)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03056586

Recruitment Status : Unknown

Verified March 2017 by Klein zvi, Meir Medical Center.
Recruitment status was: Not yet recruiting

First Posted : February 17, 2017

Last Update Posted : March 7, 2017

Sponsor:

Information provided by (Responsible Party):

Klein zvi, Meir Medical Center

Study Description

Brief Summary:

Genital prolapse is a common complain. 30-40% of women will complain of uterine prolapse or cystocele or rectocele, or mixed. About half of them will require surgical repair for the prolapse, with or without hysterectomy. Of these patients about 30-40% will have recurrence of the prolapse, which in some cases requires second operation.

In this study the investigators want to investigate whether a vaginal pessary inserting in the end of the primary surgery, for 4 weeks, will reduce the recurrence rate.

Condition or disease	Intervention/treatment	Phase
Use of Pessary Reduce the Number of Prolapse Recurrence Uterine Prolapse Cystocele Rectocele	Device: vaginal pessary	Not Applicable

Detailed Description:

All patients going for vaginal surgery for genital prolapse, stage 3-4, with cystocele, rectocele or uterine cervix prominent from the vagina. These patients, after signing an informed consent, a vaginal pessary will insert at the end of the operation and will stay for 4 weeks post-op.

After 4 weeks the pessary will be removed, and the patient will followed for 2 years, for recurrence of prolapse.

Study Design

Layout table for study information

Study Type :	Interventional (Clinical Trial)
Estimated Enrollment :	100 participants
Allocation:	Non-Randomized
Intervention Model:	Parallel Assignment
Masking:	Single (Participant)
Primary Purpose:	Prevention
Official Title:	The Recurrence Rate of Genital Prolapse Post Repair With the Use of PESSARY for One Month Post Operative
Estimated Study Start Date :	March 20, 2017
Estimated Primary Completion Date :	December 20, 2018
Estimated Study Completion Date :	December 20, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pelvic Support Problems

U.S. FDA Resources

Arms and Interventions

Arm	Intervention/treatment
Experimental: 1. study group 100 patients who agree to participate in the study, will be operate according to our protocol for pelvic organ prolapse. At the end of the operation a vaginal pessary will be inserted and suture to the vaginal walls for a 4 week period. Follow-up will be after 3, 6, and 12 month period.	Device: vaginal pessary A vaginal pessary will be inserted at the end of the operation, for genital prolapse, and will be sutured to the vaginal wall. The pessary will stay in the vagina for 4 weeks.
No Intervention: 2. control 100 Women who will refuse to participate in the study, will agree to be follow-up by our team for 3, 6, and 12 month post operative.

Outcome Measures

Primary Outcome Measures :

Reduction of recurrence rate of vaginal prolapse, post vaginal surgery repair. [ Time Frame: 24 month ]
The investigators hope to see a low percentage of prolapse recurrence in the study (pessary) group, comparing to the control (no pessary) group

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	30 Years to 80 Years (Adult, Older Adult)
Sexes Eligible for Study:	Female
Gender Based Eligibility:	Yes
Gender Eligibility Description:	women
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

all healthy patients with genital prolapse grade 3-4, going for vaginal surgery
age 30-80years

Exclusion Criteria:

patients with pelvic inflammatory disease
patients after pelvic irradiation
large vaginal erosion
vaginal bleeding uncontrolled or undiagnosed
patients going for surgery with mesh

Contacts and Locations

No Contacts or Locations Provided

More Information

Layout table for additonal information

Responsible Party:	Klein zvi, Head of urogynecology unit, Meir Medical Center
ClinicalTrials.gov Identifier:	NCT03056586
Other Study ID Numbers:	0188-16-MMC
First Posted:	February 17, 2017 Key Record Dates
Last Update Posted:	March 7, 2017
Last Verified:	March 2017

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	Yes
Product Manufactured in and Exported from the U.S.:	No

Additional relevant MeSH terms:

Layout table for MeSH terms

Rectocele Cystocele Uterine Prolapse Recurrence Prolapse Disease Attributes Pathologic Processes Pathological Conditions, Anatomical Urinary Bladder Diseases	Urologic Diseases Pelvic Organ Prolapse Uterine Diseases Rectal Diseases Intestinal Diseases Gastrointestinal Diseases Digestive System Diseases Hernia

To Top